Cargando…

Anti-VEGF-A Affects the Angiogenic Properties of Tumor-Derived Microparticles

Tumor derived microparticles (TMPs) have recently been shown to contribute to tumor re-growth partially by inducing the mobilization and tumor homing of specific bone marrow derived pro-angiogenic cells (BMDCs). Since antiangiogenic drugs block proangiogenic BMDC mobilization and tumor homing, we as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munster, Michal, Fremder, Ella, Miller, Valeria, Ben-Tsedek, Neta, Davidi, Shiri, Scherer, Stefan J., Shaked, Yuval
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994111/ https://www.ncbi.nlm.nih.gov/pubmed/24752333 http://dx.doi.org/10.1371/journal.pone.0095983

Ejemplares similares

The antiangiogenic role of the pro-inflammatory cytokine interleukin-31
por: Davidi, Shiri, et al.
Publicado: (2017)

Host response to immune checkpoint inhibitors contributes to tumor aggressiveness
por: Khononov, Irina, et al.
Publicado: (2021)

Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015)

Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy()()
por: Hasnis, Erez, et al.
Publicado: (2014)

On-site education of VEGF-recruited monocytes improves their performance as angiogenic and arteriogenic accessory cells
por: Avraham-Davidi, Inbal, et al.
Publicado: (2013)

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
por: Itatani, Yoshiro, et al.
Publicado: (2018)

Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling
por: Stratman, Amber N., et al.
Publicado: (2020)

Anti-Angiogenic Effect of Asperchalasine A Via Attenuation of VEGF Signaling
por: Park, Jun Yeon, et al.
Publicado: (2019)

Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy
por: van Beijnum, Judy R., et al.
Publicado: (2022)

The endogenous anti-angiogenic VEGF isoform, VEGF(165)b inhibits human tumour growth in mice
por: Rennel, E S, et al.
Publicado: (2008)

Coaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF Therapies
por: Zhang, Leilei, et al.
Publicado: (2015)

VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010)

Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale
por: Harris, Sheila, et al.
Publicado: (2012)

The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy
por: Carter, James G., et al.
Publicado: (2014)

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies
por: Guyot, Mélanie, et al.
Publicado: (2016)

Direct and Indirect Modulation of T Cells by VEGF-A Counteracted by Anti-Angiogenic Treatment
por: Bourhis, Morgane, et al.
Publicado: (2021)

An anti-angiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease
por: Kikuchi, Ryosuke, et al.
Publicado: (2014)

Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs
por: Künnapuu, Jaana, et al.
Publicado: (2021)

VEGF-independent angiogenic pathways induced by PDGF-C
por: Li, Xuri, et al.
Publicado: (2010)

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts
por: Dore-Savard, Louis, et al.
Publicado: (2016)

Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications
por: Stahl, Andreas, et al.
Publicado: (2012)

Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms: A NOVEL THERAPEUTIC STRATEGY FOR ANGIOGENESIS
por: Nowak, Dawid G., et al.
Publicado: (2010)

Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2
por: Scheuer, Werner, et al.
Publicado: (2016)

Breast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by Chemotherapy
por: Shechter, Dvir, et al.
Publicado: (2020)

Lymphocytic Microparticles Modulate Angiogenic Properties of Macrophages in Laser-induced Choroidal Neovascularization
por: Tahiri, Houda, et al.
Publicado: (2016)

Anti-endothelial cell antibodies are associated with apoptotic endothelial microparticles, endothelial sloughing and decrease in angiogenic progenitors in systemic sclerosis
por: Michalska-Jakubus, Małgorzata M., et al.
Publicado: (2019)

Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response
por: De Rosa, Lucia, et al.
Publicado: (2016)

Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo
por: Foy, Kevin C., et al.
Publicado: (2012)

Association between the ratio of anti-angiogenic isoform of VEGF-A to total VEGF-A and adverse clinical outcomes in patients after acute myocardial infarction
por: Harada, Kazuhiro, et al.
Publicado: (2018)

Anti-angiogenic efficacy of 5′-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs
por: Yuan, Dongmei, et al.
Publicado: (2015)

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
por: Gerhardt, Holger, et al.
Publicado: (2003)

Angiogenic Potential of VEGF Mimetic Peptides for the Biofunctionalization of Collagen/Hydroxyapatite Composites
por: Wang, Suya, et al.
Publicado: (2021)

VEGF Regulation of Angiogenic Factors via Inflammatory Signaling in Myeloproliferative Neoplasms
por: Subotički, Tijana, et al.
Publicado: (2021)

A Cyclic Peptide Epitope of an Under-Explored VEGF-B Loop 1 Demonstrated In Vivo Anti-Angiogenic and Anti-Tumor Activities
por: Wang, Lei, et al.
Publicado: (2021)

Effects of High Intensity Training and High Volume Training on Endothelial Microparticles and Angiogenic Growth Factors
por: Wahl, Patrick, et al.
Publicado: (2014)

Pro-angiogenic effect of RANTES-loaded polysaccharide-based microparticles for a mouse ischemia therapy
por: Suffee, N., et al.
Publicado: (2017)

Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunction
por: Marei, Isra, et al.
Publicado: (2022)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing
por: Mavrou, Athina, et al.
Publicado: (2016)

Dynamics and implications of circulating anti-angiogenic VEGF-A(165)b isoform in patients with ST-elevation myocardial infarction
por: Hueso, Luisa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6f2fvf3d2c64qg37qede834sm9